Prescription drug price transparency

The following resources are for reporting entities who may need assistance with prescription drug price transparency. 

Want to stay up-to-date on prescription drug price transparency?

Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)

The following resources are for reporting entities who may need assistance.

The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.

Important note about Excel version: We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.

New DPT login process goes live November 15

Starting November 15, reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login. 

All

Carriers

Report year 2021 (due date: October 1, 2022)

Report year 2020 (due date: December 1, 2021)

Manufacturers

Report year 2023 (draft - comments due by November 7, 2022)

Report year 2022

Pharmacy Benefit Managers (PBMs)

Report year 2021 (draft - comments due by November 7, 2022)

Report year 2020 (due date: March 1, 2022)

Report years 2018-2019

Pharmacy Services Administrative Organizations (PSAOs)

Report year 2021 (due date: October 1, 2022)

Report year 2020 (due date: December 1, 2021)

Stakeholder meetings

At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.

Meeting schedule

Date and time Meeting type Materials
July 28, 2021 PBM listening session

Slide deck

Listening session audio

July 22, 2021 Manufacturer listening session

Slide deck

Listening session audio

July 6, 2021 Carrier listening session

Slide deck

Listening session audio

April 29, 2020

Pharmacy benefit manager / pharmacy service administrative organization reporting

Webinar only, no in person meeting due to COVID-19

Slide deck

Recorded webinar

April 1, 2020

Issuer / carrier reporting

Webinar only, no in person meeting due to COVID-19

Updated slide deck

Recorded webinar

February 26, 2020 Manufacturer reporting

Slide deck

Recorded webinar

Background

In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).

Reports

Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.

Contact

Program questions and information
Email: HCA Drug Price Transparency - general inquiry

Technical data related questions, or any questions regarding the data submission process
Email: HCA Drug Price Transparency - tech support

Protections for insurance consumers and insurance industry oversight
Contact: Washington State Office of the Insurance Commissioner (OIC)